- Home
- / Celltrion Pharm
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Celltrion Pharm financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩62.9 K
2024-10-29
Market Capitalization
₩2.6 T
2024-10-29
Revenue
₩536.4 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 146.9B | 173.5B | 233.6B | 398.7B | 386.0B | 388.8B | 477.8B | 536.4B |
| Cost of goods sold | 67.4B | 74.7B | 114.7B | 131.2B | 225.4B | 252.1B | 339.4B | 353.2B |
| Gross profit | 79.6B | 98.9B | 119.0B | 267.7B | 160.8B | 136.9B | 138.5B | 183.4B |
| Gross profit margin, % | 57.0% | 51.0% | 67.1% | 35.2% | 29.0% | 34.2% | ||
| Operating expense total | 63.0B | 70.7B | 81.5B | 203.2B | 105.0B | 81.0B | 81.3B | 105.1B |
| Depreciation and amortization | 16.6B | 13.3B | 13.5B | 16.4B | 17.4B | 22.4B | 20.1B | 22.5B |
| EBITDA | 16.6B | 28.2B | 37.6B | 64.5B | 55.8B | 55.9B | 57.2B | 78.3B |
| EBITDA margin, % | 16.3% | 16.1% | 16.2% | 14.4% | 12.0% | 14.6% | ||
| EBIT | (860.6M) | 14.4B | 23.7B | 47.7B | 36.9B | 33.1B | 36.4B | 53.9B |
| EBIT margin, % | 8.3% | 10.1% | 12.0% | 8.5% | 7.6% | 10.0% | ||
| Interest income | 606.5M | 274.9M | 323.7M | 399.4M | 1.1B | 1.3B | 1.6B | 2.6B |
| Interest expense | 6.0B | 5.2B | 4.6B | 5.4B | 6.2B | 8.3B | 7.5B | 6.7B |
| Pre tax profit | (6.3B) | 8.8B | 20.1B | 42.5B | 30.5B | 26.2B | 29.8B | 49.7B |
| Income tax expense | 3.1B | 242.7M | (811.8M) | 7.9B | 4.5B | 4.9B | 7.8B | 11.0B |
| Net Income | (9.4B) | 8.6B | 20.9B | 34.6B | 26.0B | 21.3B | 22.0B | 38.8B |